Ian sits down with Mark Jones, our head of IT and leader of Veramed’s VENN team, to discuss how Veramed responded to Covid-19, touching on company strategy, our approach to employees, flexibility, employee development and more.
Ian sits down with our Chief Business Officer, Stuart McGuire, to discuss the clinical trials industry, what’s in store, what’s changed and what they think are the big talking points for 2022.
What motivates us as Statisticians and Programmer? Why do we do it? Where does one get their inspiration? And what role do we play in helping patients? Ian sits down with Alexander Schacht, Executive VP of Launch and Commercialisation Data Sciences at Veramed to discuss why they entered the industry, what keeps them motivated, and how to find inspiration.
Ian sits down with Andrew Horden, Marketing Manager at Veramed, to discuss the world renowned B Corp movement, what it means, why we certified, the process of certification, and what Veramed has in store for B Corp month.
Ian sits down with Jon Gibbs and Jasmin Moussaoui from Veramed’s Recruitment team to discuss Veramed Germany, our recruitment process within the German market, how we maintain our culture, and more.
Ian sits down with Diana Stuart, our Guardian of Culture, to discuss the importance of company culture, its link to employee happinness and engagement, how Veramed approaches culture, and how we maintain it.
Rhys recalls his experience working through Veramed’s Graduate Training Programme (GTP), why he joined Veramed and what he got out of the experience. Rhys is now a full-time Statistician I at Veramed.
Abby Fuller, Principal Statistician at Veramed, discusses the challenges and pleasant surprises she found while working at large CRO compared to a medium-sized CRO in Veramed.
